Lack of clinically relevant drug interactions between bictegravir/emtricitabine/tenofovir alafenamide and ledipasvir/sofosbuvir or sofosbuvir/velpatasvir/voxilaprevir [P264]

Garrison KL, Humenluk R, West SK, et al. Lack of clinically relevant drug interactions between bictegravir/emtricitabine/tenofovir alafenamide and ledipasvir/sofosbuvir or sofosbuvir/velpatasvir/voxilaprevir [P264]. Presented at HIV Drug Therapy/Glasglow; October 28-31, 2018. Glasglow, United Kingdom; 2018.

Publication Type:

Conference Proceedings

Authors:

Garrison, KL; Humenluk, R; West, SK; et, al

Source:

Presented at HIV Drug Therapy/Glasglow; October 28-31, 2018, Glasglow, United Kingdom (2018)

Cited On:

Export Citation:
RIS Format
Top